Menu

F-star Therapeutics, Inc. FSTX

Full chart Compare
Set alert

Price alert · FSTX

All alert types
7.12 +7.12

Day range unavailable

52-week range unavailable

Revenue & Expenses

Income Tax Benefit → Expenses: $372.00KExpenses → Selling, General & Admin: $23.13MExpenses → Research & Development: $28.75MExpenses → Interest Expense: $844.00KExpenses → Other Expenses: $97.00KGross Profit → Expenses: $21.17MRevenue → Gross Profit: $21.17MNet Loss → Expenses: $31.28MIncome Tax Benefit$372.00KGross Profit$21.17MNet Loss$31.28MExpenses$52.82MSelling, General & Admin$23.13MResearch & Development$28.75MInterest Expense$844.00KOther Expenses$97.00KRevenue$21.17M

Latest period ending Dec 31, 2021 · select a line to chart its full history

FSTX annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
21.17M11.26M28.32M00
21.17M11.26M28.32M00
-30.71M-22.39M-22.50M-28.47M-21.25M
-31.28M-25.62M-23.01M-22.85M-27.68M
-1.88-9.69-14.89-7.52-9.92
FSTX annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
78.55M18.53M4.90M14.96M24.13M
123.02M63.61M38.48M68.81M52.34M
26.16M20.61M29.94M12.95M17.59M
13.23M3.16M15.57M00
96.86M42.99M8.54M55.86M34.75M
FSTX annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-27.27M-16.23M-22.11M-25.24M-17.68M
-643.00K14.05M5.37M-25.10M-12.41M
88.10M15.85M13.26M41.17M43.54M
-643.00K00-1.97M-323.00K
60.19M13.67M-3.48M-9.18M13.45M